Memorial Sloan Kettering reports insufficient human evidence for major medical uses of graviola supplements.
On this page
Food and supplemental extracts are different
Soursop or graviola refers to Annona muricata, a tropical tree with an edible fruit. Products may contain fruit, leaves, powders or concentrated extracts. Safety and composition cannot be inferred from a person’s experience eating the fruit.
What researchers have examined
Laboratory experiments have explored biological activity of graviola extracts, but findings from cells or animals do not demonstrate that supplements improve health outcomes in people. Memorial Sloan Kettering notes that clinical evidence supporting use for major diseases is lacking.
Medication and safety questions
MSK reports that graviola may interact with medicines used for blood sugar or blood pressure. Preclinical neurological safety concerns have also been described, and uncertainty remains about their meaning for humans. These are reasons for careful professional review rather than reasons to make definitive product-specific predictions.
ProstaPeak and the missing quantitative panel
The seller refers to soursop among ProstaPeak’s named botanicals. Without exact product quantities, form or finished-product trials, it is not possible to conclude what exposure an individual receives from the marketed supplement.
Why cure language is inappropriate
Do not interpret claims about cancer cells or inflammation in a laboratory as evidence of cancer treatment or prostate symptom relief. An ingredient cannot replace assessment of urinary complaints or evidence-based disease treatment.
Further reading on this topic
We may receive a commission when a reader buys through marked affiliate links. This is an independent information site, not the manufacturer. The content is not medical advice or proof of ProstaPeak efficacy.
Check Seller’s Current Offer ↗Sources and references
Seller statements are identified as seller-reported. Sources do not endorse this site or product. Reviewed November 1, 2026.